Myriad Genetics buy The Goldman Sachs Group, Inc.
Start price
17.04.25
/
50%
€6.75
Target price
17.04.26
€12.32
Performance (%)
-37.54%
End price
18.04.26
€4.22
Summary
This prediction ended on 18.04.26 with a price of €4.22. Massive losses of -37.54% were the result for the BUY prediction by The_Goldman_Sachs_Gr. The_Goldman_Sachs_Gr has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Myriad Genetics | -2.622% | -2.622% | 36.330% |
| iShares Core DAX® | 0,07 % | 0,24 % | 2,89 % |
| iShares Nasdaq 100 | -1,34 % | -3,37 % | 29,21 % |
| iShares Nikkei 225® | -2,31 % | -7,50 % | 56,32 % |
| iShares S&P 500 | -0,34 % | 0,90 % | 23,17 % |
Comments by The_Goldman_Sachs_Gr for this prediction
In the thread Myriad Genetics diskutieren
Myriad Genetics, Inc. (NASDAQ: MYGN) had its price target lowered by analysts at The Goldman Sachs Group, Inc. from $18.00 to $14.00. They now have a "buy" rating on the stock.
Ratings data for MYGN provided by MarketBeat
In the thread Trading Myriad Genetics
Die von The_Goldman_Sachs_Gr gewählte maximale Laufzeit wurde überschritten